Current State Of Molecular and Serologic Testing for SARS-CoV-2
Learning Objectives:
- Describe the current landscape of COVID-19 molecular diagnostics including regulatory oversight.
- Outline the limitations and pitfalls of current diagnostic testing for COVID-19.
- Review the serological testing and their appropriate use, interpretation and limitations.
Erin H. Graf, Ph.D.
Co-Director, Microbiology
Senior Associate Consultant Laboratory Medicine and Pathology, Mayo Clinic Arizona
Erin Johnson Kaleta, Ph.D.
Assistant Professor of Laboratory Medicine and Pathology, College of Medicine,
Senior Associate Consultant, Laboratory Medicine and Pathology, Mayo Clinic Arizona
LOCATION Zoom Link
ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.
TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.
ABOUT Cancer Center Grand Rounds are held on Thursdays for faculty and junior faculty, investigators and junior investigators, scholars, graduate students, medical students, research fellows, administration and allied health staff.
ARCHIVED PRESENTATIONS Located in Arizona Cancer Center Grand Rounds Video Library
For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.

Facebook
X
LinkedIn
Forward